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Altered synaptic function has been associated with neurological and psychiatric
conditions including intellectual disability, schizophrenia and autism spectrum disorder
(ASD). Amongst the recently discovered synaptic proteins is p140Cap, an adaptor
that localizes at dendritic spines and regulates their maturation and physiology. We
recently showed that p140Cap knockout mice have cognitive deficits, impaired long-term
potentiation (LTP) and long-term depression (LTD), and immature, filopodia-like dendritic
spines. Only a few p140Cap interacting proteins have been identified in the brain
and the molecular complexes and pathways underlying p140Cap synaptic function
are largely unknown. Here, we isolated and characterized the p140Cap synaptic
interactome by co-immunoprecipitation from crude mouse synaptosomes, followed by
mass spectrometry-based proteomics.We identified 351 p140Cap interactors and found
that they cluster to sub complexes mostly located in the postsynaptic density (PSD).
p140Cap interactors converge on key synaptic processes, including transmission across
chemical synapses, actin cytoskeleton remodeling and cell-cell junction organization.
Gene co-expression data further support convergent functions: the p140Cap interactors
are tightly co-expressed with each other and with p140Cap. Importantly, the p140Cap
interactome and its co-expression network show strong enrichment in genes associated
with schizophrenia, autism, bipolar disorder, intellectual disability and epilepsy, supporting
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synaptic dysfunction as a shared biological feature in brain diseases. Overall, our data
provide novel insights into the molecular organization of the synapse and indicate
that p140Cap acts as a hub for postsynaptic complexes relevant to psychiatric and
neurological disorders.
Keywords: p140Cap, postsynaptic density, synaptic transmission, synaptic plasticity, schizophrenia, autism,
intellectual disability, epilepsy
INTRODUCTION
Mutations in genes encoding synaptic proteins have been
associated with several brain disorders, including schizophrenia,
autism spectrum disorder (ASD) and developmental
delay/intellectual disability (DD/ID) (De Rubeis et al., 2014;
Fromer et al., 2014; Deciphering Developmental Disorders,
2015). The term “synaptopathies” has in fact been proposed to
cover a broad range of clinical manifestations having synaptic
dysfunction as common etiology (Grant, 2012). The synaptic
genes implicated in brain diseases span several functional classes,
including adhesion molecules (e.g., NRXN1; Kim et al., 2008),
neurotransmitter receptors (e.g., GRIN2B ; Endele et al., 2010),
voltage-gated ion channels (e.g., SCN2A; Rauch et al., 2012),
scaffolding proteins of the postsynaptic density (PSD) (e.g.,
SHANK3; Betancur and Buxbaum, 2013) and signaling proteins
(e.g., SYNGAP1 ; Hamdan et al., 2009).
Enormous progress has been made in the characterization of
the synaptic proteome (Bayes et al., 2014), and the molecular and
functional dissection of specific subsynaptic complexes is likely
to reveal novel genes relevant to brain pathophysiology. Amongst
the recently discovered synaptic proteins is p140Cap/SNIP (Chin
et al., 2000; Di Stefano et al., 2004), a scaffolding protein localized
in dendritic spines (Jaworski et al., 2009) and encoded by the
SRCIN1 gene. Previous work from our laboratory and others
indicates that p140Cap is key in regulating synaptogenesis,
synaptic transmission and synaptic plasticity (Jaworski et al.,
2009; Tomasoni et al., 2013; Repetto et al., 2014). Acute
down-regulation of p140Cap in primary hippocampal neurons
reduces the number of mushroom spines and proportionally
increases the number of dendritic filopodia (Jaworski et al.,
2009; Tomasoni et al., 2013), a defect in synaptic maturation
that can also be observed in p140Cap knockout (KO) mice
(Repetto et al., 2014). Notably, dendritic spine dysgenesis is
a consistent neuroanatomical finding in several psychiatric
disorders, including ID, ASD and schizophrenia (Penzes et al.,
2011). Further, p140Cap KO mice display defective long-term
potentiation (LTP) and reduced long-term depression (LTD), two
forms of synaptic plasticity necessary for learning and memory.
Consistently, p140Cap KO mice show impairments in object
recognition, suggestive of defects in memory consolidation and
retrieval cognitive defects (Repetto et al., 2014).
The molecular complexes and pathways underlying p140Cap
function are largely unknown. p140Cap was originally identified
as an interactor of SNAP-25 in a two-hybrid screen (Chin
et al., 2000) and subsequent studies have shown that this
interaction takes place in the PSD, involving also PSD95, and
is required for spine morphogenesis (Tomasoni et al., 2013;
Fossati et al., 2015). p140Cap had been also shown to interact
with other components of the pre-synaptic compartment, such as
vinexin and synaptophysin (Ito et al., 2008). Other interactions
necessary for p140Cap-mediated control of spine formation
and/or maturation are those with the EB3 (Jaworski et al., 2009),
Endophilin A1 (Yang et al., 2015), and Src kinase (Di Stefano
et al., 2007; Repetto et al., 2013, 2014). EB3 binds the plus-
end of growing microtubules that can enter dendritic spines and
influence their morphology (Jaworski et al., 2009). Endophilin
A1 is localized both presynaptically, where it regulates synaptic
vesicle endocytosis, and postsynaptically, where it controls spine
morphogenesis (Yang et al., 2015). The correct functioning
of both EB3 and Endophilin A1 requires p140Cap and its
downstream effector cortactin, an F-actin-binding protein, that
regulates the actin cytoskeleton organization (Uruno et al.,
2001). The p140Cap-dependent regulation of cortactin activity
might require a direct interaction as well as the suppression of
the Src kinase pathway. In fact, cortactin is inhibited by Src
phosphorylation (Martinez-Quiles et al., 2004), and p140Cap
directly binds Src (Di Stefano et al., 2007) and suppresses its
activation through binding to the C-terminal Src kinase (Csk) (Di
Stefano et al., 2007; Repetto et al., 2013). Consistently, synapses
isolated from p140Cap KO mice have increased phosphorylation
on Src kinase Tyrosine 416 (Repetto et al., 2014) and treatment
with a specific Src inhibitor ameliorates the spine defects
observed in p140Cap KO neurons (Repetto et al., 2014). Beyond
its role in spine morphology, p140Cap-mediated suppression
of Src has been recently implicated in the homeostatic brake
that restrains cocaine reward in the nucleus accumbens (Damez-
Werno et al., 2016).
Given the role of p140Cap in synaptogenesis and the
repercussions on cognition in its absence, we sought to capture
the p140Cap molecular complexes at synapses and investigate
their relevance for brain disorders. By using biochemical,
proteomic, gene co-expression, and genetic data, we provide a
comprehensive analysis of the p140Cap synaptic interactome.
Our results reveal that p140Cap acts as a hub for synaptic proteins
implicated in psychiatric and neurological disorders.
MATERIALS AND METHODS
Animals
Mixed 129Sv × C57BL/6J p140Cap heterozygous mice were
generated as described in (Repetto et al., 2014). All experiments
were approved and performed in accordance with the Italian law
(authorization D.M. n◦279/95B 27/11/1995) and dispositions of
“D.L. n◦116, 27/1/1992 in relation to animal use and protection
in scientific research.” Male, 3-month old wild-type (WT) and
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p140Cap knockout (KO) littermates were used for synaptosomes
preparations. Animals were sacrificed by cervical dislocation.
Synaptosomes Preparation
Synaptosomes were prepared from the telencephalon. The
tissue was homogenized with a Dounce glass homogenizer
and glass pestle in 8ml ice-cold synaptosome buffer (4mM
Hepes pH = 7.3, 320mM sucrose, 1mM EGTA, Roche protease
inhibitors 25X, 1mM Sodium Orthovanadate, 1mM DTT,
phenylmethylsulphonyl fluoride, 1mM sodium fluoride). The
homogenate was centrifuged at 1,000 g for 10min at 4◦C. After
discarding the nuclear pellet, the supernatant was centrifuged
at 12,500 g for 20min at 4◦C. The pellet containing the
synaptosomal fraction was resuspended in the synaptosome
buffer and further centrifuged at 12,500 g for 20min at 4◦C.
The final pellet (crude synaptosome fraction) was resuspended
in 2ml of ice-cold lysis buffer (150mM NaCl, 50mM Tris pH
= 7, 5% Glycerol, 1% NP-40, 1mM MgCl2, Roche protease
inhibitors 25X, 1mM Sodium Orthovanadate, 1mM DTT,
phenylmethylsulphonyl fluoride, 1mM sodium fluoride) and
immediately processed for immunoprecipitation (Figure S1).
Western Blot
Western blots were performed with Mini-PROTEAN R© TGXTM
Precast Gels from Bio-Rad (California 94547 USA).gradient 4–
15% Gels were transferred on Nitrocellulose blotting membrane
(GE Healthcare Life Sciences) using Towbin buffer (25mM
Tris, 192mMGlycine, 20%Methanol). Membranes were blocked
with Tris-buffered saline TBS (50mM Tris p < h 7–150mM
NaCl) with 5% Milk for 1 h at room temperature, incubated
with primary and secondary antibodies as indicated below,
and then developed with Bio-Rad’s Clarity ECL on ChemiDoc
Touch Imaging System (Biorad). For western blot of crude
synaptosomal proteins, 30 ug of proteins was used.
Antibodies
Specific mouse monoclonal antibody (Mab) against p140Cap
(clone 2A8) was produced at the MBC, University of Torino,
as previously described (Di Stefano et al., 2007; Repetto
et al., 2013). The antibodies used are as follows: Dlg4 (Mab,
Abcam), Citron-N (rabbit polyclonal, Abcam), Grin2A (rMab
from Millipore; rabbit polyclonal from Thermo Scientific),
Grin2b (mouse monoclonal antibody, Neuromab), Grin1 rabbit
polyclonal (Thermo Scientific), Shank2 (rabbit polyclonal,
Synaptic System), Shank3 (rabbit polyclonal, Synaptic System),
Snap25 (Mab, Synaptic System), Actin I-19 (rabbit polyclonal,
Santa Cruz Biotechnology), Trio (rabbit polyclonal, Santa
Cruz Biotechnology), rabbit polyclonal Camk2 (Cell Signaling),
Homer-1 (rabbit polyclonal, Thermo Scientific), Cadherin-11
(Mab, Thermo Scientific), Syncam (rabbit polyclonal, Thermo
Scientific), Ttc3 (rabbit polyclonal, as described in Berto et al.,
2007), and Gfap (Mab, Dako-Agilent Technologies), Bassoon
(rabbit polyclonal, Synaptic System). Mouse and rabbit IgGs were
purchased from Santa Cruz Biotechnology. Secondary antibodies
anti-mouse and anti-rabbit were purchased from Sigma Aldrich.
p140Cap Immunoprecipitation
1.25mg of Dynabeads protein G (30mg Dynabeads R©/mL
Invitrogen, Carlsbad, CA, USA) were initially washed using a
Sodium Acetate buffer (100mM Sodium acetate pH = 5, 0.1%
NP-40) and incubated with 6 µg of p140Cap antibody diluted
in the same buffer for 1 h at room temperature under gentle
rotation. Beads were then washed twice withSodium acetate
buffer and with Sodium Borate buffer (0.2M Sodium borate
pH = 9, 0.1% NP-40) Crosslinking was performed with 25mM
Dymethil Pimelimidate in 1ml of Sodium Borate buffer for 45
min at room temperature on a wheel. Beads were washed again
with Sodium Borate buffer and then with 0.2 M Ethanolamine
pH = 8, 0.1% NP-40, incubated for 1 h at RT on a wheel to block
the N-reactive groups and washed twice in PBS 0.1% NP-40. To
remove the non-cross-linked antibody, beads were suspended in
100mM Glycine pH = 2.5 and rapidly washed in 50mM Tris
pH = 7.4 0.1% NP-40. p140Cap-coupled Dynabeads were then
washed twice with PBS 1X 0.05% Tween and then incubated
with 6mg of crude synaptosomal extracted for 2 h at 4◦C. Beads
were washed five times with cold lysis buffer, then resuspended
in 60 µl of 2% SDS-PAGE sample buffer in reducing conditions
and incubated at 70◦C for 10min. From this 1mg was tested
for Coomassie staining, 1mg for Western blot for p140Cap to
control the quality of the samples and 4mg was used for mass
spectrometry (Figure S2).
Primary Hippocampal Cultures
Primary cultures were established from the hippocampus of
17.5–18.5 embryos derived from breeding of p140Cap ± mice.
The dissociated cells were plated on 20 mm coverslip coated
with poly-lysine at the density of 80,000 cells/coverslip and
cultured in Neurobasal medium (Invitrogen) added with B27
(Invitrogen), supplemented with antibiotics, 2mM glutamine
and glutamate for 17–18 days at 37◦C. Neurons were then fixed in
paraformaldehyde 4% and sucrose 4% (Sigma Aldrich) for 8min
at room temperature.
Immunofluorescence and Microscopy
Immunofluorescence staining was performed using antibodies
against PSD95 (1:500 mouse monoclonal Abcam) and p140Cap
homemade monoclonal antibody conjugated with Alexa Fluor
647 Antibody labeling kit (Thermo Fisher) diluted 1:500.
Coverslips were first incubated with anti-PSD95 and then with
Alexa fluor 488 goat anti mouse (Invitrogen); after several washes
of the secondary antibody, conjugated anti-p140Cap Mab was
added for 1h at room temperature and then washed away. Images
were acquired using a Leica SPE confocal microscope.
Mass Spectrometry
(1) Preparation and in-gel digestion of proteins: proteins from
co-IP eluates were stacked in the top of a 4–12% NuPAGE
gel (Invitrogen) and stained with R-250 Coomassie blue.
Gel bands were manually excised and cut in pieces before
being washed six times with 25mM NH4HCO3 for 15min,
followed by six washes in 25mM NH4HCO3 containing 50%
(v/v) acetonitrile. Gel pieces were then dehydrated with 100%
acetonitrile and incubated with 10 mM DTT in 25 mM
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NH4HCO3 for 45min at 53
◦C and with 55mM iodoacetamide
in 25 mM NH4HCO3 for 35min in the dark. Alkylation
was stopped by adding 10mM DTT in 25 mM NH4HCO3
(incubation for 10min). Gel pieces were then washed again
by incubation in 25mM NH4HCO3followed by dehydration
with 100% acetonitrile. Modified trypsin (Promega, sequencing
grade) in 25mM NH4HCO3 was added to the dehydrated
gel pieces before overnight incubation at 37◦C. Peptides were
extracted from gel pieces in three sequential extraction steps
(each 15 min) using 30 µl of 50% acetonitrile, 30 µl of
5% formic acid, and finally 30 µl of 100% acetonitrile. The
pooled supernatants were dried under vacuum. (2) Nano-LC-
MS/MS analyses: the dried extracted peptides were resuspended
in 5% acetonitrile and 0.1% trifluoroacetic acid and analyzed
by online nanoLC-MS/MS (UltiMate 3000 RSLCnano and Q-
Exactive Plus, Thermo Scientific) with 2 replicates per sample.
Peptides were sampled on a 300 µm x 5 mm PepMap C18
precolumn and separated on a 75 µm × 250mm C18 column
(PepMap, Dionex). The nanoLC method consisted of a 120-
min gradient at a flow rate of 300 nl/min, ranging from 5
to 37% acetronitrile in 0.1% formic acid for 114 min, before
reaching 72% acetronitrile in 0.1% formic acid for the last 6 min.
Spray voltage was set at 1.6 kV; heated capillary was adjusted
to 270◦C. Survey full-scan MS spectra (m/z = 400–1,600) were
acquired with a resolution of 70,000 after accumulation of 106
ions (maximum filling time 200 ms). The 10 most intense
ions were fragmented by higher-energy collisional dissociation
after accumulation of 105 ions (maximum filling time 50
ms). MS and MS/MS data were acquired using the software
Xcalibur (Thermo Scientific). (3) Data analyses: RAW files were
processed using MaxQuant, version 1.5.1.2 (Cox and Mann,
2008). Spectra were searched against the Uniprot database (Mus
musculus taxonomy, March 2015 version) and the frequently
observed contaminants database embedded in MaxQuant. The
I = L option was activated. Trypsin was chosen as the enzyme
and 2 missed cleavages were allowed. Peptide modifications
allowed during the searchwere: carbamidomethylation (C, fixed),
acetyl (Protein N-ter, variable) and oxidation (M, variable).
Minimum number of unique peptides was set to 1. The matching
between runs option was activated. The mass spectrometry
proteomics data have been deposited to the ProteomeXchange
Consortium via the PRIDEpartner repository (Vizcaino et al.,
2016) with the dataset identifier PXD004215. (4) Statistical
analyses: The following steps were mainly performed using the
Perseus toolbox (version 1.5.1.6) available in the MaxQuant
environment. Proteins identified in the reverse and contaminant
databases, identified with less than 2 razor + unique peptides,
or exhibiting less than 6 iBAQ values in one condition (3
biological replicates with 2 analytical replicates each for control
and p140Cap co-IPs) were discarded from the list. iBAQ values
of the 1952 remaining proteins. After log2 transformation, iBAQ
values were normalized by condition-wise centering, missing
data imputation was realized (replacing missing values by a
constant weak value calculated independently for each injected
sample as the 2.5-percentile value of the column) and statistical
testing of differential abundances between control and p140Cap
conditions were conducted using welch t-testing. To consider
a protein as a potential binding partner of p140Cap, it must
has passed our significance criteria: FDR threshold of 1% on p-
values using the Benjamini-Hochberg method and a minimum
4-times enrichment in p140Cap WT samples compared to the
KO controls.
Bioinformatic Analyses of MS Data
Throughout the study, over-representation of annotation
terms (disease, function etc.) was estimated by use of the
hypergeometric distribution to test whether the number of
selected proteins is larger than would be expected by chance;
p = 1−
k−1∑
i=0
(
M
i
) (
N−M
n−i
)
(
N
n
)
where N is a total number of proteins in the background
distribution, M is the number of genes within distribution that
are annotated to the node of interest, n is the size of the list
of genes of interest and k is the number of genes within the
list, which are annotated to the node. Obtained p-values were
adjusted for multiple testing by Bonferroni correction at 0.05 or
0.01 significance levels as indicated.
For literature comparison, a list of 6,688 proteins was
selected as a synaptic universe based on combined results
from 35 published synapse proteome studies (in preparation;
Supplementary Table S2). Protein lists from those studies were
curated, mapped to stable IDs (Entrez, Uniprot, MGI) for
human and mouse and combined into single list containing only
unique protein/gene name, IDs and publication source (PMID).
Summary data for the 35 publications with associated metadata
(PMID, year, method, species and number of proteins found) are
presented in Supplementary Table S2).
Enrichment analysis of annotation in the interactome was
performed in R, specifically using the Bioconductor package
ClusterProfiler for Gene Ontology (GO) and KEGG enrichment
analysis (Yu et al., 2012) and Bioconductor ReactomePA package
for pathway over-representation analysis (http://bioconductor.
org/packages/release/bioc/html/ReactomePA.html). For each
enrichment type (GO, KEGG, Reactome), two background
sets of proteins were used: (1) the default mouse genome list
from Bioconductor and (2) our list of 6688 published synaptic
proteins-to reveal the consistency in enriched terms. p-values,
adjusted for multiple comparison p.adjust and q-values for false
discovery rates (FDR) are provided in Supplementary Table S3.
For disease enrichment the annotation data were standardized
usingMetaMap (Aronson and Lang, 2010) andNCBOAnnotator
(Whetzel et al., 2011; Musen et al., 2012) to recognize terms
found in the Human Disease Ontology (HDO) (Schriml et al.,
2012) Recognized enriched disease ontology terms were then
associated with gene identifiers and stored locally. Disease term
enrichment’, for the p140Cap dataset’, could then be calculated
using the Topology-based Elimination Fisher method (Alexa
et al., 2006) found in the topGO package (http://topgo.bioinf-
mpi-inf.mpg.de/), together with the standardized OMIM and
Ensembl variation gene-disease annotation data (14111 gene-
disease associations), mapped onto the full HDO tree.
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A PSD network was constructed from a list of 1,443 proteins
obtained from a study of the PSD in the human brain (Bayes et al.,
2011). Protein-protein interactions were obtained by mining
publicly available databases: HIPPIE (Schaefer et al., 2012),
BioGRID (Chatr-Aryamontri et al., 2015), IntAct (Kerrien et al.,
2012), and performing an InterologWalk over different species
using Bio::Homology::InterologWalk (Gallone et al., 2011). The
connected PSD network consists of 1,312 proteins and 8,031
protein interactions (i.e., 131 proteins could not be connected
into the network). This PSD network was clustered making
use of the spectral properties of the network; the network
being expressed in terms of its eigenvectors and eigenvalues,
and partitioned recursively (using a fine-tuning step) into
communities based on maximizing the Modularity clustering
measure (Newman, 2006; Simpson et al., 2010). Where first we
found the node which, when moved from one community to
the other, gave the maximum change in Modularity. This node’s
community was then fixed and we repeat the process until all
nodes had been moved. The whole process was repeated from
this new state until the change in the Modularity, between the
new and old state, was less than the predefined tolerance. The
modularity of the full PSD network was found to be 0.36.
Robustness of the full PSD network communities was
assessed by running the algorithm 500 times, randomly selecting
80% of the network node set and related interactions each
time. The package clusterCons (Simpson et al., 2010) was
used to build a consensus matrix from which to test the
robustness of the communities, and proteins found inside
the communities. Community and protein robustness values
range from 0, indicating no confidence in existing through
to 1, indicating absolute confidence in the cluster existing.
Community robustness values range from 0.1 to 0.7, and from
0.01 to 0.9 for protein robustness. Clusters C7, C17, C22, and C23
showed evidence of being robust, with community robustness
values 0.2, 0.4, 0.3, and 0.3 respectively.
We also tested the significance of annotation enrichment
in each cluster using the Hypergeometric distribution formula.
P ≤ 10−2, were tested for their strength of significance
by recording the percentage of P-values found from every
community/annotation combination, lower than or equal to
the observed P-value, when 1,000 random permutations of the
annotation labels were made. P-values found with a strength
of significance < 1% were considered statistically significant.
P-values values were also tested against a more stringent
Bonferroni correction at the 0.05 (∗), 0.01 (∗∗), and 0.001 (∗∗∗)
significant levels, and highlighted throughout the enrichment
tables.
Gene Co-expression Analysis
Gene co-expression was evaluated on 18 human-mouse
conserved co-expression networks (CCNs) (Piro et al., 2011),
where a link of co-expression reflects the human and mouse
independent gene co-expression in the corresponding single-
species networks. Statistical significance of p140Cap interactors
co-expressed with p140Cap was assessed by hypergeometric
distribution. Statistical significance of the co-expression between
p140Cap interactors was assessed by evaluating the p-value of
the z-score corresponding to the number of links found in the
single CCNs, based on 100 randomization of the same CCNs.
RESULTS
Quantitative Proteomic Analysis of
p140Cap Synaptic Interactome
To identify the p140Cap protein complexes and the related
functional pathways at synapses, we performed a quantitative
proteomic analysis of p140Cap immunoprecipitates from mouse
crude synaptosomes preparations, using p140Cap KO mice
(Repetto et al., 2014) as negative control (Figure S1). The quality
of the preparations was verified by testing the enrichment of
synaptic proteins in the crude synaptosome fraction compared
to total brain extracts. PSD-95, SNAP-25, and Bassoon, as well as
p140Cap, were enriched in synaptosomes (Figure 1A).
Three distinct crude synaptosomes were prepared from 3
month-old WT and p140Cap KO male mice and synaptosomal
extracts were immunoprecipitated using p140Cap monoclonal
antibody. The specificity of the immunoprecipitates (IP) was
confirmed by Coomassie staining and western blot (Figure S2).
In the Coomassie-stained gel, we detected a discrete band of
∼150 kDa, corresponding to the expected molecular weight
for p140Cap in SDS-PAGE in the IPs from WT samples but
not from p140Cap KO synaptosomes (Figure S2A). Similarly, a
p140Cap immunoreactive band was observed in the p140Cap
IPs from WT but not from KO synaptosomes (Figure S2B).
The Coomassie-stained gel reveals that several proteins seem
to selectively co-immunoprecipitate with p140Cap from WT
samples as compared with the KO ones. Overall, these data
indicate that the p140Cap immunoprecipitation is highly specific,
thus making these samples suitable for the identification of
p140Cap interactors by mass spectrometry (MS).
To identify p140Cap-binding partners, we applied label-free
quantitative MS-based proteomics to the p140Cap IPs from WT
and KO synaptosomes. Proteins eluted from the IPs were in-
gel digested and the resulting peptides analyzed by nanoliquid
chromatography coupled to tandemMS (two analytical replicates
per sample). Identities and intensities of the recovered peptides
and proteins in each sample were obtained usingMaxQuant (Cox
and Mann, 2008). After filtering and statistical analysis of iBAQ
values (Schwanhausser et al., 2011), 352 (351 interactors plus
p140Cap) proteins enriched in the WT samples were identified
(Supplementary Table S1), as represented in the Volcano plot
(Figure 1B).
To validate the proteomic findings, we selected eleven
candidates whose alterations might underlie the dendritic spine
defects, the impairments in LTP/LTD, and the learning and
memory deficits we previously observed in the p140Cap KO
mice (Repetto et al., 2014). We then tested the presence of the
selected proteins on the p140Cap IPs. We tested and validated
p140Cap interactions with Citron-N, already known to interact
with p140Cap (Repetto et al., 2014); the NMDA receptor subunits
Grin2a, Grin2b and Grin1, the scaffold proteins Dlg4/PSD95,
Shank2, Shank3, Homer1, and Camk2a. Alterations in expression
or localization of several of these interactors are known to
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FIGURE 1 | Identification and validation of p140Cap interactors. Enrichment of synaptic markers in the synaptosomal preparation. (A) Validation of the synaptosomes.
Western blot for p140Cap, PSD-95, Snap25, Bassoon and beta-actin fractions isolated during synaptosomal preparation. Lane 1, nuclear fraction (P1); lane 2, first
cytosolic fraction (S1); lane 3, second cytosolic fraction (S2); lane 4, crude synaptosome (P2), lane 5, total brain extracts (see Figure S1 for details). (B) Statistically
enriched proteins in the p140Cap IP. The Volcano plot represents the log10(p-value, y axis) plotted against the log2(fold change, x axis) for proteins quantified in
p140Cap IPs from WT and p140Cap KO, used as negative control. 357 different proteins, including p140Cap (arrowhead) were found significantly enriched in WT
samples (FDR ≤ 1%, ≥ 4-fold enrichment) are shown as green dots (C) Validation of synaptic p140Cap interacting proteins identified in the interactome. Lane 1 and
5, p140Cap IP in WT animals; lane 2 and 6, p140Cap IP in p140Cap KO animals; lane 3 and 7, input from WT synaptosomes; lane 4 and 8, input from KO
synaptosomes. Co-immunoprecipitated proteins are shown on the left, along with their rank in MS. (D) Reverse validation for p140Cap interacting proteins
Dlg4/PSD95 and Grin2a/NR2A. Lane 1, Dlg4/PSD95 IP in WT animals; lane 2, Dlg4/PSD95 IP in p140Cap KO animals; lane 4, input from WT synaptosomes; lane 5,
input from KO synaptosomes; lane 6, Grin2a/NR2A IP in WT animals; lane 7, Grin2a/NR2A IP in p140Cap KO animals; lane 9, input from WT synaptosomes; lane 10,
input from KO synaptosomes. Lane 3 and lane 8 are control IP with IgGs in WT animals.
affect LTP/LTD and cognitive functions (Grant, 2012; Luscher
and Malenka, 2012; Robison, 2014; Sweatt, 2016). Further, we
validated the interaction with the adhesion molecules Cadherin-
11 (Cdh11) (Manabe et al., 2000) and Cadm1/Syncam (Frei and
Stoeckli, 2016; Figure 1C). We also verified that three proteins
(Ttc3, Trio, and Gfap), placed very low in the interactome, were
only non specifically immunoprecipitated with anti p140Cap
Mab (Figure S3). Further, we performed a reverse validation: we
immunoprecipitated PSD95 andGrin2a and verified the presence
of p140Cap (Figure 1D). The validation of the proteomic data
across a range of various enrichment levels above the fixed
cut-off indicates that the p140Cap synaptic interactome we
isolated contains bona fine p140Cap-containing macromolecular
complexes.
Synaptic Localisation of p140CAP
Complexes with Comparative Study of
Reported Synaptic Datasets
To further map the p140Cap interactome, we searched published
neuronal proteome datasets for p140Cap and its interactors.
We found that p140Cap was reported in the majority of the
Frontiers in Molecular Neuroscience | www.frontiersin.org 6 June 2017 | Volume 10 | Article 212
Alfieri et al. p140Cap as a Hub for Proteins Involved in Synaptopathies
published PSD datasets (Supplementary Table S2). In a few co-
IP studies, p140Cap was detected in complexes with PSD95
(Dosemeci et al., 2007), mGluR5 (Farr et al., 2004), Chmpb2
(Chassefeyre et al., 2018), and Snap25 (Fossati et al., 2015).
Further, we searched for the 351 identified interactors of p140Cap
across the published PSD proteomic datasets and found an
exceptionally high enrichment (order of E-14 of significance in
average) (Supplementary Table S2).
We also sought to verify whether p140Cap and associated
proteins were found in presynaptic preparations as well, and
we found that p140Cap was detected in the presynaptic
compartment in several studies (Gronborg et al., 2010; Boyken
et al., 2013; Weingarten et al., 2014). Specifically, it was detected
in complexes with Rims1, Syn1-2-3, Git1, and Wasf1 in co-
IP experiments on presynaptic protein complexes (August B
Smit, personal communication). However, it was not reported
in other studies focusing on synaptic vesicles (SV) or SV-
recycling proteins (Morciano et al., 2005, 2009; Gorini et al.,
2010; Brinkmalm et al., 2014; Wilhelm et al., 2014). p140Cap–
interacting proteins, in turn, were found enriched in presynaptic
datasets, although with a lower score than that found in
postsynaptic studies (Supplementary Table S2). Therefore, our
proteomic data, in agreement with previous studies, place
p140Cap mainly, but not exclusively, in the PSD.
We then examined all the p140-interacting proteins to
evaluate their distribution between pre- and postsynaptic
complexes. The two lists showed a high degree of overlap,
which was expected since the majority of synaptic proteins are
found in both compartments. Figure 2A shows the distribution
of the p140-interacting proteins between PSD (5023 proteins
from 25 postsynaptic studies and presynaptic compartment (1215
proteins from 9 presynaptic studies). 334 of the 352 p140Cap
interactors overlap with these datasets. Of these proteins, none
were described as specifically presynaptic, whereas the majority
was described as specifically postsynaptic (247) or found in
both compartments (87). This further supports a predominantly
postsynaptic localization of the p140Cap complexes.
The presence of p140Cap in the PSD has been previously
shown in rat synaptic fractionation, where it is enriched in
the PSD fraction together with PSD95 (Mclean Colin et al.,
2016). To further validate the presence of p140Cap in the PSD,
we performed a localization experiment on primary mouse
hippocampal cultures. Staining of both p140Cap and PSD95
in Figure 2B shows a co-localization of these two proteins at
synapses. All together, these results strongly indicate that the
p140Cap-associated proteins share common cellular functions
and fall within specific substructures of the PSD.
Functional Enrichment Analyses of the
p140CAP-Containing Protein Complexes
To obtain a functional perspective of the p140Cap interactome,
we tested its enrichment against KEGG, GO ontology and
Reactome databases (Supplementary Table S3). We ran analysis
against two reference (background) lists: (1) the default mouse
genome list provided by Bioconductor and (2) a combined list
of 6688 proteins from published synapse proteomics studies,
to reveal more specific p140Cap associated terms compared to
the whole synaptosome. Both reference lists demonstrated a
very high level of consistency in top enriched terms. However,
using the synaptic as background gives more conservative (i.e.,
lower) significance values for enriched terms. The full lists for
enrichment results are presented in Supplementary Table 3.
For the enriched terms listed here, p-values were corrected
for multiple testing as described in the methods. Based on
Molecular Function (MF) ontology, the 351 p140Cap-interacting
proteins were significantly enriched for the “actin binding” term
(P = 2.79E-17), which is in line with the previously described
functions of p140Cap (Repetto et al., 2014). Additionally,
we found that “glutamate receptor binding” (P = 3.46E-11),
“PDZ domain binding” (P = 1.22E-06) and “GTPase regulator
activity” (P = 2.86E-04) terms were also significantly increased
(Supplementary Table S3). Among the top Cellular Compartment
(CC) terms were “postsynaptic membrane” (P = 3.08E-27),
“actin cytoskeleton” (P = 2.87E-14), and “neurotransmitter
receptor complex” (P = 8.53E-10). This is in agreement with
Biological Process (BP) GO results, where the top enriched
terms were “chemical synaptic transmission” (P = 1.81E-15),
“actin cytoskeleton organization” (P = 4.37E-11), “regulation
of synaptic plasticity” (P = 1.96E-09) and “regulation of
protein complex assembly” (P = 3.63E-06) (Supplementary
Table S3). Analysis of enrichment against the Reactome pathway
database revealed the overrepresentation for “Transmission
across Chemical Synapses” (P = 7.05E-15), “Unblocking of
NMDA receptor, glutamate binding and activation” (P = 4.90E-
10), “Cell-cell junction organization” (P = 1.44E-08), “Ras
activation upon Ca influx through NMDA receptor” (P = 2.49E-
08), “L1CAM interactions” (P = 1.00E-07) (Supplementary
Table S3).
To classify proteins into functionally related modules, we
checked for the correlation between the experimentally measured
protein abundances and Reactome pathway terms for the top
174 interacting proteins with the highest significance. Three
“modules” could be detected (Figure 3). Module 1 (Figure 3,
upper right) is related to “Unblocking and activating NMDA
receptors,” “Trafficking of AMPA receptors” and “Chemical
signaling through the synapse” Reactome terms (including Gria1,
Gria3, Grin2B, and Dlg4). Module 2 (Figure 3, center), is largely
composed of cadherin-, claudin- and catenin-related proteins
involved in “Cellular adhesion and junction” functions. Module
3 (Figure 3, bottom left) includes proteins associated in “Axon
Guidance” and “Developmental Biology” function.
Taken together, the functional enrichment analysis from these
three distinct sources (GO, Reactome and KEGG) indicate that
the p140Cap interactors exhibit functions relevant to synaptic
structure, synaptic transmission and plasticity.
The p140CAP Interactome within the
Structure of the PSD
Given the enrichment in PSD (Figure 2A), we examined
previously described PSD protein network models to assess
whether the p140Cap-interacting proteins form structural
composites within the PSD or are rather randomly distributed
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FIGURE 2 | p140Cap interacting proteins distribution in pre- and postsynaptic compartments and functional modules of the p140Cap interactome. (A) Venn diagram
showing the overlap of 352 p140Cap interactors (green) mapped in pre- (purple) and postsynaptic (yellow) datasets. (B) p140Cap co-localization with PSD95 on
primary hippocampal neurons. DIV 17 hippocampal neurons were stained with antibodies to p140Cap (red) and to PSD95 (green). Merge is shown on the right (Upper
panels) Scale bar 20 µm. Magnification of a segment of dendrite is shown in lower panels.
throughout the network. We built a protein-protein interaction
(PPI) network based on a human PSD protein dataset combined
with the interaction data from several public databases (see
Materials and Methods and Mclean Colin et al., 2016 for details).
Spectral cluster analysis was performed on the network as
described in Mclean Colin et al. (2016). Within the PSD network
of 1,312 proteins, we identified 60 structural clusters based on the
network topography. Essentially each cluster contains proteins
that are more densely connected to other proteins within the
cluster than to proteins elsewhere in the network (Figure 4).
Functional enrichment was tested for each of the clusters
to assess structure/function relationships within the molecular
network (the distribution of the proteins between the clusters
and enrichment results are shown in Supplementary Table S4).
We then mapped the p140Cap-interacting proteins onto the
network and identified the clusters that are more strongly
enriched for p140Cap-interacting proteins compared to a
random distribution. We found 4 clusters with significant
over-representation for p140Cap-interacting proteins: Cluster
7 (Figure 4B) (14/61, P = 3.5E-02), Cluster 17 (12/21,
P = 3.62002E-06), Cluster 22 (28/80, P = 7.05E-07), and
Cluster 23 (13/39, P = 1.4E-03). Cluster 22 (Figure 4D) is
overrepresented with GO BP “glutamate receptor signaling
pathway,” “endocytosis,” “cell-cell signaling,” and “synaptic
transmission” terms and contains the main PSD scaffolding
proteins of the MAGUK family and their interactors. This
cluster was also significantly enriched with proteins from
functional Module 1 (see Figure 3). Cluster 23 (Figure 4E),
was found to be associated with GO BP term “cell junction
assembly,” and was enriched with proteins from Module 2 (see
Figure 3). Cluster 7 (Figure 4B), was overrepresented with the
“cytoskeleton organization,” “actin cytoskeleton organization”
and “cell junction assembly” terms and it contains proteins from
Module 3 (Figure 3, Supplementary Table S4).
Co-expression Analysis of p140CAP
Interactors
To assess whether the expression of p140Cap interacting proteins
could also be co-regulated, we isolated the top significant
174 p140Cap-interacting proteins with an unequivocal Entrez
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FIGURE 3 | Heatmap of the Reactome Pathway enrichment analysis clustering. Intensity is based on the average relative protein abundance in MS. Three main
modules are observed: upper right, Module 1; center, Module 2; and, bottom left, Module 3.
gene ID and tested their co-expression using 18 human-
mouse conserved co-expression networks (CCNs) (Piro et al.,
2011).
We found a statistically significant number of p140Cap
interactors co-expressed with p140Cap in “All Samples,” “Normal
Tissues,” “Brain,” and “Central Nervous System” conserved co-
expression networks (Supplementary Tables S5, S6). The co-
expression across p140Cap interactors was also significant in
six CCNs (Supplementary Table S7), including “All Samples,”
“Normal Tissues,” “Brain,” and “Central Nervous System”
networks (Supplementary Table S8).
Overall, these data show that the network of p140Cap-
interacting proteins also reflects a gene co-expression cluster
(Figure 5), indicating that the components of the p140Cap
interactome might undergo coordinated mechanisms of tissue-
specific transcription control.
Disease Enrichment of p140Cap Related
Proteins
Synaptic dysfunction has emerged as a common theme in
neurological and psychiatric disorders, and recent large-scale
genetic studies in ASD and schizophrenia (De Rubeis et al., 2014;
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FIGURE 4 | The p140Cap-interactome within the PSD (A) Clusters in the full PSD network. 60 structural clusters where obtained, including 4 significantly enriched for
p140Cap–interacting proteins (purple), magnified in panels B–E. (B) Components of Cluster 7. The cluster is overrepresented with “cytoskeleton organization,” “actin
cytoskeleton organization,” and “cell junction assembly” terms and contains p140Cap interactors from Module 3. (C) Components of Cluster 17. This cluster is
associated with trans-synaptic signaling and contains p140Cap interacting proteins from Module 3. (D) Components of Cluster 22. The cluster includes the main
MAGUK and scaffold proteins and associated with “glutamate receptor signaling pathway,” “endocytosis,” “cell-cell signaling,” and “synaptic transmission” terms and
contains the majority of the proteins from Module 1. (E) Components of Cluster 23. The cluster is associated with cell adhesion function and cell junction functions
and is enriched with proteins from Module 2.
Fromer et al., 2014) have further strengthened this hypothesis.
The pathophysiological mechanisms might include abnormal
expression of discrete synaptic proteins or the inability to
organize into functional macromolecular complexes (Bayes et al.,
2011). We investigated the disease enrichment of the genes
encoding p140Cap interactingmolecules (351 genes), using gene-
disease annotation data collected from OMIM (http://omim.
org/) and Ensembl variation (Chen et al., 2010) databases
mapped onto the HDO tree using the topOnto package (https://
github.com/statbio/topOnto). These analyses yielded a core
background list of 14,111 gene-disease associations mapped
onto 1,491 HDO terms. We also considered lists of risk genes
and loci emerged from recent studies, including ASD (Sanders
et al., 2015), epilepsy (EuroEPINOMIC-RES Consortium, 2014),
Bipolar Disorder (Kataoka et al., 2016) and Schizophrenia
(Fromer et al., 2014; Schizophrenia Working Group of the
Psychiatric Genomics, 2014). The 826 gene-disease associations
resulting from these analyses were then merged with the
annotation set from the databases, yielding a total of 14,357 gene-
disease associations mapped onto 1,491 HDO terms. Using the
Topology-based Elimination Fisher method (Alexa et al., 2006),
we found that the p140Cap dataset is significantly enriched for
genes associated with schizophrenia (P = 2.1E-9), ASD (P =
7.9E-6), bipolar disorder (P = 5.3E-5), ID (1.1E-3), and epilepsy
(1.7E-3) (Table 1, Supplementary Table S9).
Moreover, a further and independent evidence in supporting
the role of p140Cap in neurological diseases came from the
observation that the largest connected component of the sub-
network of co-expression links of p140Cap-interactors among
themselves and p140Cap in the All Tissues CCN contains several
genes labeled as Disease Genes and involved in neurological
diseases. These results indicate that p140Cap pathways, defined
by both protein-protein interactions and gene co-expression
data, are relevant to psychiatric and neurological disorders.
DISCUSSION
The structure and the combinatorial use of a handful of
modulatory elements give rise to complexity at subcellular,
cellular, and systems level at the synapse (Grant et al., 2016).
The loss or modification of key synaptic proteins can directly
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FIGURE 5 | The co-expression sub-network of p140Cap and its interactors
contains relevant disease genes. The most connected component of the
co-expression network in “All Tissues CCN.” p140Cap is shown in red,
disease genes are in yellow.
affect such network, ultimately impacting synaptic function. Our
results allow to propose that the p140Cap adaptor molecule
acts as a key hub of synaptic networks. Our work is the first
comprehensive proteomic analysis of the synaptic interactome
of p140Cap, which is indispensable for dendritic spine initiation
and maturation and forms of hippocampal synaptic plasticity
(Repetto et al., 2014). Our data show that the most prominent
localization of p140Cap is within the PSD, with a significant
enrichment for pathways related to receptors trafficking and
chemical signaling through the synapse, cellular adhesion
and junction, and axon guidance. We also provide evidence
that the p140Cap interactome forms a gene co-expression
module. Although p140Cap itself has not been implicated in
brain disease yet, our results unveil a robust association of
the p140Cap interactome with neurological and psychiatric
disorders, including schizophrenia, ID, epilepsy and ASD.
Some of the p140Cap-interacting proteins associated to brain
disorders have unknown functions in the brain. By mapping
them to the synaptic p140Cap interactome, our study provides
functional cues on these disease genes, including ROGDI,
FRMD4A, and TRANK1. Loss of ROGDI, encoding a protein with
unknown function, causes Kohlschutter-Tonz syndrome (MIM
614574), which presents with psychomotor delay, early-onset
intractable seizures, variable ID correlating with the severity
of seizures, and amelogenesis imperfect (Schossig et al., 2012).
Genetic disruption of FRMD4A causes a syndrome characterized
by congenital microcephaly accompanied by agenesis of corpus
callosum and/or partial hypoplasia of the vermis and cerebellum
and ID (Fine et al., 2015) (MIM 616819). FRMD4A regulates
cell polarity in non-neuronal cells (Ikenouchi and Umeda, 2010)
and the microcephaly and brain malformations reported in
carriers of FRMD4A mutations are compatible with defects in
cell polarity in neuronal progenitors and/or newborn neurons.
Beyond early brain development, our data also point to a synaptic
function for FRMD4A. TRANK1 is a GWAS-associated locus
for both schizophrenia (Schizophrenia Working Group of the
Psychiatric Genomics, 2014) and bipolar disorder (Chen et al.,
2013; Muhleisen et al., 2014), but its functional roles in neurons
are obscure. Again, our results locate it in the p140Cap synaptic
network.
There is robust evidence supporting the hypothesis that
synaptic dysfunction is a shared mechanism underlying a broad
range of brain disorders, and our data further corroborate it. For
example, alterations in glutamatergic transmission can result in
a broad spectrum of psychiatric conditions. In our dataset, we
detected AMPA and NMDA receptor subunits associated with
schizophrenia (i.e., GRIA1 and GRIN2A) and with a spectrum
of DD/ID, ASD and seizures, often in co-morbidity (GRIA3,
GRIN1, GRIN2A, and GRIN2B). Glutamatergic transmission
is intertwined with synaptic calcium dynamics (Higley and
Sabatini, 2012), and large-scale genetic studies have shown that
disruption of voltage-gated calcium channels is a pathological
mechanism across psychiatric disorders (Cross-Disorder Group
of the Psychiatric Genomics, 2013). Notably, this pathway
holds potential for rapid therapeutic intervention (Lencz and
Malhotra, 2015). Seven VGCC subunits were found in the
p140Cap interactome and four of them are associated to
disease. CACNA1A haploinsufficiency can cause episodic ataxia
type 2 (MIM 108500), familial hemiplegic migraine type 1
(MIM 141500) and spinocerebellar ataxia 6 (MIM 183086).
More recently, CACNA1A mutations have been described in
individuals diagnosed with ID, epilepsy, ADHD and/or ASD
(Damaj et al., 2015). CACNA2D1 and CACNA2D2 are both
associated with epilepsy and ID (Edvardson et al., 2013; Pippucci
et al., 2013; Vergult et al., 2015), while CACN2D3 has been
recently implicated in ASD (De Rubeis et al., 2014). Interestingly,
none of the reproducible GWAS-associated loci in schizophrenia
CACNA1C, CACNA1H, and CACNB2 (Schizophrenia Working
Group of the Psychiatric Genomics, 2014) was detected in
our dataset. However, several RIM proteins that are necessary
for VGCCs regulation, including the schizophrenia-associated
RIMS1 (Schizophrenia Working Group of the Psychiatric
Genomics, 2014), are detected in the p140Cap interactome.
Psychiatric manifestations are often accompanied by defects
in neuronal morphogenesis, and abnormalities of dendritic
spines (either the number or the shape), which are one of
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TABLE 1 | Disease enrichment of p140Cap related proteins.
TERM.ID Term Annotated Significant Expected classicFisher elimFisher
DOID:5419 Schizophrenia 1600 65 30.54 2.1E-09 2.1E-09
DOID:12849 ASD 338 20 6.45 7.9E-06 7.9E-06
DOID:3312 Bipolar disorder 981 37 18.72 5.3E-05 5.3E-05
DOID:1059 Intellectual disability 490 20 9.35 1.18E-03 1.18E-03
DOID:1826 Epilepsy 331 15 6.32 1.78E-03 1.78E-03
The table shows the 5 top terms for the TopGo disease enrichment with results from Fisher and elimFisher tests. The agreement among the orders of magnitude for both methods
indicates the strong over-representation of respective disease genes among the p140Cap interacting proteins.
the most robust neuroanatomical correlate of ID and often a
finding in ASD and schizophrenia (Penzes et al., 2011). p140Cap
and many of its interactors play a role in the formation,
maturation and maintenance of dendritic spines. Specifically,
deficiency of p140Cap results in an excess of immature filopodial-
like protrusions at the expenses of mature mushroom spines
(Tomasoni et al., 2013; Repetto et al., 2014). Depletion, ablation
or mutations of many p140Cap interactors, including CNKSR2
(CNK2) (Lim et al., 2014), CTNNB1 (β-catenin) (Okuda et al.,
2007), CTNND2 (δ-catenin) (Arikkath et al., 2009), phenocopy
these defects. Conversely, other p140Cap-associated proteins are
needed for spine maintenance and their silencing results in
reduced spine density and/or spine shrinkage, as documented for
CASK (Chao et al., 2008) and ANK3 (Smith et al., 2014). All
these genes are associated with psychiatric conditions, ranging
from ID i.e., CNKSR2 (Kessels and Malinow, 2009; Vaags et al.,
2014), CTNNB1 (Tucci et al., 2014), ANK3 (Iqbal et al., 2013),
CASK (Tarpey et al., 2009) and ASD i.e., CTNND2 (Turner et al.,
2015), ANK3 (Iqbal et al., 2013) to schizophrenia i.e., CNKSR2
(GWAS, PGC-SCZ 2014) and bipolar disorder ANK3 (Ferreira
et al., 2008).
Similarly, the impairment in LTP and LTD and the deficits
in memory and learning observed in the p140Cap KO mice
(Repetto et al., 2014) could be sustained by improper functioning
and/or localisation of several of these newly identified p140Cap
interactors, such as the NMDARs subunits, the AMPA receptors,
PSD-95, and the Shank family.GRIN1,GRIN2A, andGRIN2B are
key in LTP induction, synaptic plasticity, learning and memory
(Bliss and Collingridge, 1993; Bliss et al., 2014; Shipton and
Paulsen, 2014). Synaptic trafficking of AMPARs is necessary
for the induction of LTP, and GluR1-deficient mice exhibit
impaired hippocampus-dependent spatial working memory and
one-trial spatial memory (Kessels and Malinow, 2009). In mice
lacking PSD-95, NMDA-dependent LTP and LTD frequency is
shifted to enhanced LTP, consistent with severely impaired spatial
learning (Migaud et al., 1998). Mice mutant for Shank proteins
exhibit a large spectrum of defects in LTP and LTD (Yoo et al.,
2014). Identifying the molecular complexes controlling forms
of plasticity that underlie memory consolidation and retrieval
has direct implications for ID and associated co-morbidities,
including ASD and ADHD. It is also important for psychiatric
disorders with a cognitive impairment component and/or with
a premorbid cognitive deficit, as documented in schizophrenia
(Reichenberg et al., 2010).
As mentioned above, SRCIN1 has not been genetically
associated with psychiatric disorders. A de novo missense
variant resulting in a p.Glu912Asp change predicted to be
probably damaging by the bioinformatic predictor Polyphen-2
and not detected in the 60,706 unrelated controls of the Exome
Aggregation Database (ExAC) was found in a schizophrenia
cohort (Fromer et al., 2014). Further, based on the data in ExAC,
SRCIN1 is significantly depleted in both loss-of-function and
missense variants, indicating that the gene is highly intolerant
to detrimental variation and so likely a source of disease risk if
mutated.
In conclusion, our findings place p140Cap at the crossroad
of a highly susceptible synaptic network disrupted in psychiatric
and neurological disorders. These findings reinforce the current
hypothesis that synaptic dysfunction is a component of all
these disorders and have repercussions on our understanding
of the underpinnings of psychiatric disorders and their shared
comorbidity.
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